Blood Journal
Leading the way in experimental and clinical research in hematology

Survival advantage associated with heterozygous factor V Leiden mutation in patients with severe sepsis and in mouse endotoxemia

  1. Bryce A. Kerlin,
  2. S. Betty Yan,
  3. Berend H. Isermann,
  4. John T. Brandt,
  5. Rashmi Sood,
  6. Bruce R. Basson,
  7. David E. Joyce,
  8. Hartmut Weiler, and
  9. Jean-Francois Dhainaut
  1. From the Blood Research Institute, Blood Center of Southeast Wisconsin and Medical College of Wisconsin, Milwaukee; Lilly Research Laboratories, Eli Lilly & Company, Indianapolis, IN; and Department of Intensive Care, Cochin Hospital, AP-HP, Cochin Institute, Cochin Port-Royal Medical School, Paris V University, Paris, France.

You do not have access to the full text of this article, the first page of the PDF of this article appears below.

PDF extract preview

To view this item, select one of the options below

If you already have a subscription, you may gain access using your ASH username and password.

Sign In for Institutional Administrators

If you are a Librarian or institutional account administrator you can use this link to manage your account and view usage reports.


Purchase Short-Term Access

Pay per Article - You may access this article (from the computer you are currently using) for 1 day for US$35.00.
Regain Access - You can regain access to a recent Pay per Article purchase if your access period has not yet expired.

OpenAthens Users

Log in through your institution

Sign Up

Subscribe to the Journal - Subscribe to the print and/or online journal.

Access for Patients

Access for Patients - Patients desiring access should contact the journal.